白细胞介素-1β诱导的胰腺炎通过B淋巴细胞介导的免疫抑制促进胰腺导管腺癌
本研究利用KC-IL1β小鼠模型及体外3D培养、流式细胞术和免疫组化等方法,发现IL-1β通过增加CXCL13表达和B淋巴细胞浸润、上调PD-L1和调节性B细胞、增加IL-35并抑制CD8+ T细胞活性,促进胰腺导管腺癌发生;人类PDAC样本中肿瘤内B细胞浸润高者生存期显著更短。
要点
- KC-IL1β小鼠发生PDAC伴肝转移,IL-1β处理增加Kras+/G12D胰腺球状体形成。
- 过继转移KC-IL1β小鼠B淋巴细胞促进肿瘤形成,清除B细胞则阻止KC-IL1β小鼠肿瘤进展。
- KC-IL1β小鼠B细胞PD-L1表达更高、调节性B细胞更多、CD8+ T细胞活性受损;清除IL-35减少PD-L1+ B细胞。
核心结论
- IL-1β部分通过诱导免疫抑制性B细胞扩增促进肿瘤发生,B抑制细胞在胰腺肿瘤发生中具有重要意义。
研究设计与样本
- 将LSL-Kras+/G12D;Pdx1-Cre(KC)小鼠与过表达IL-1β的转基因小鼠杂交,生成KC-IL1β小鼠并进行纵向随访。
- 采用胰腺3D体外培养评估腺泡-导管化生形成,通过流式细胞术和免疫组化分析免疫细胞。
- 在Kras突变小鼠中进行B淋巴细胞过继转移或清除,并分析人类PDAC样本中B细胞浸润。
主要发现
- KC-IL1β小鼠发生PDAC伴肝转移。
- IL-1β处理增加Kras+/G12D胰腺球状体形成。
- KC-IL1β胰腺中CXCL13表达和B淋巴细胞浸润增加。
- 过继转移KC-IL1β小鼠B淋巴细胞促进肿瘤形成,清除B细胞则阻止KC-IL1β小鼠肿瘤进展。
- KC-IL1β小鼠分离的B细胞PD-L1表达更高、调节性B细胞更多、CD8+ T细胞活性受损并促进肿瘤发生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Long-standing chronic pancreatitis is an established risk factor for pancreatic ductal adenocarcinoma (PDAC). Interleukin-1β (IL-1β) has been associated in PDAC with shorter survival. We employed murine models to investigate the mechanisms by which IL-1β and chronic pancreatitis might contribute to PDAC progression. DESIGN: We crossed LSL-Kras+/G12D;Pdx1-Cre (KC) mice with transgenic mice overexpressing IL-1β to generate KC-IL1β mice, and followed them longitudinally. We used pancreatic 3D in vitro culture to assess acinar-to-ductal metaplasia formation. Immune cells were analysed by flow cytometry and immunohistochemical staining. B lymphocytes were adoptively transferred or depleted in Kras-mutant mice. B-cell infiltration was analysed in human PDAC samples. RESULTS: KC-IL1β mice developed PDAC with liver metastases. IL-1β treatment increased Kras+/G12D pancreatic spheroid formation. CXCL13 expression and B lymphocyte infiltration were increased in KC-IL1β pancreata. Adoptive transfer of B lymphocytes from KC-IL1β mice promoted tumour formation, while depletion of B cells prevented tumour progression in KC-IL1β mice. B cells isolated from KC-IL1β mice had much higher expression of PD-L1, more regulatory B cells, impaired CD8+ T cell activity and promoted tumorigenesis. IL-35 was increased in the KC-IL1β pancreata, and depletion of IL-35 decreased the number of PD-L1+ B cells. Finally, in human PDAC samples, patients with PDAC with higher B-cell infiltration within tumours showed significantly shorter survival. CONCLUSION: We show here that IL-1β promotes tumorigenesis in part by inducing an expansion of immune-suppressive B cells. These findings point to the growing significance of B suppressor cells in pancreatic tumorigenesis.
引用
- Takahashi R, Macchini M, Sunagawa M, et al. Interleukin-1β-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression. Gut. 2020. PMID: 32393543. doi:10.1136/gutjnl-2019-319912
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。